Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04081688
Title Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.